PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection

Title
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection
Authors
Keywords
Vaccination and immunization, Parasitemia, Parasitic diseases, Enzyme-linked immunoassays, Vaccines, Blood, Sporozoites, Vaccine development
Journal
PLoS Pathogens
Volume 17, Issue 5, Pages e1009594
Publisher
Public Library of Science (PLoS)
Online
2021-05-29
DOI
10.1371/journal.ppat.1009594

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started